Thomas Malley stock trades
Director at Kiniksa Pharmaceuticals International and Kura Oncology
No open-market buys or sales reported in the last 12 months. Their newest Form 4, for May 29: stock unit conversion (2,799 KNSA shares).
The 2 companies Thomas Malley files at
Each title as their newest Form 4 there gives it, and the open-market trades there in the last 12 months. Open any stock for its score. Pro members see every stock ranked.
| Company | Trades | Quality Score |
|---|---|---|
| 0 | ||
| 0 |
Thomas Malley's trades, as filed
None on the open market in the last 12 months.
2 other filings on record (option exercise and stock unit conversion). Pro members see every filing and the shares Thomas Malley holds.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Here is what Pro members see.
- Prices refresh every 2.5 seconds during market hours.
- Optional alerts by push, email, or the bell.
- Add it to your Home Screen and it opens like an app.
Others who file at their companies
- Sanj K. Patel
- Mark Ragosa
- Eben Tessari
- John F. Paolini
- Michael R. Megna
- Ross Moat
- Barry D. Quart
- G. Bradley Cole
- Felix Baker
- Julian Baker
- Richard S. Levy
- Kimberly J. Popovits
- Tracey L. McCain
- Troy Edward Wilson
- Brian T. Powl
- Mollie Leoni
- Teresa Brophy Bair
- Thomas James Doyle
- Kathleen Ford
- Francis Burrows
- Faheem Hasnain